Articles & Research

Is esketamine covered by Medicaid in McLean, VA? Esketamine (Spravato) could be a promising solution for those suffering from severe depression. However, many patients are concerned about the affordability of this treatment. Our team at McLean Neuropsychiatric Treatmevnt Center in McLean, Virginia, is here to help you navigate Medicaid coverage for Spravato. What is Esketamine

If you’re struggling with treatment-resistant depression (TRD) and traditional medications haven’t provided relief, advanced treatments like Transcranial Magnetic Stimulation (TMS) or Spravato (esketamine) may be the solution. At McLean Neuropsychiatric Treatment Center (NTC) in McLean, Virginia, we specialize in both of these treatments. This blog will help you understand the differences between TMS and Spravato

For individuals struggling with treatment-resistant depression (TRD), finding an effective solution can often feel overwhelming. If you’ve gone through multiple antidepressants and therapies without success, you might be exploring ketamine-based options such as Spravato (esketamine). However, you may feel concerned about covering the costs. At McLean Neuropsychiatric Treatment Center (NTC), we’re here to help you

Living with depression that resists traditional treatments can be exhausting and disheartening. If you’ve tried medications, therapy, and lifestyle changes without finding relief, interventional psychiatry could be a promising solution. At McLean Neuropsychiatric Treatment Center (NTC) in McLean, VA, we specialize in this advanced approach, using innovative therapies like Spravato (esketamine) and Transcranial Magnetic Stimulation

Ketamine was initially developed as an anesthetic, but it has recently gained attention as a promising treatment for mental health conditions, particularly depression. In 2000, the first clinical trial demonstrated that ketamine could produce rapid and long-lasting improvements in patients with depression. Since then, numerous studies have underscored its potential to treat severe depression as

Ketamine nasal spray, specifically the FDA-approved Spravato (esketamine), has become a game-changer for those struggling with treatment-resistant depression. As this therapy gains traction in the DMV area, understanding how long its effects last is crucial for patients considering this treatment. In this blog post, we explore the duration of ketamine nasal spray effects, factors that